Stock listing
ALXO Stock Price, News, Filings & Events — Alx Oncology Holdings Inc.
Selected listing: ALXO · NASDAQ · USD · US
This page tracks Alx Oncology Holdings Inc.'s ALXO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALXO:NASDAQ. ALXO:NASDAQ is the stock-level entry point for investors researching Alx Oncology Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alx Oncology Holdings Inc. is a public company traded under the ticker ALXO in the American market. The company has a market capitalization of approximately $282.6 million. Alx Oncology focuses on developing innovative therapies for cancer treatment.
- Ticker
- ALXO:NASDAQ
- Asset type
- Stock
- Market cap
- $276.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Alx Oncology Holdings Inc. ALXO:NASDAQ stock context
This page tracks Alx Oncology Holdings Inc.'s ALXO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALXO:NASDAQ. ALXO:NASDAQ is the stock-level entry point for investors researching Alx Oncology Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alx Oncology Holdings Inc. is a public company traded under the ticker ALXO in the American market. The company has a market capitalization of approximately $282.6 million. Alx Oncology focuses on developing innovative therapies for cancer treatment.
Latest news from Alx Oncology Holdings Inc.
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
June 30, 2026
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
June 1, 2026
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Ca...
April 30, 2026
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
April 17, 2026
Alx Oncology Holdings Inc. earnings calls
ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call
May 8, 2026 · Replay with transcript and chapters
ALX Oncology Holdings Inc. (ALXO) Q4 2025 Earnings Call
February 27, 2026 · Replay with transcript and chapters
ALX Oncology Holdings Inc. (ALXO) Q3 2025 Earnings Call
November 7, 2025 · Replay with transcript and chapters
ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Research Alx Oncology Holdings Inc.
Alx Oncology Holdings Inc. investor report
Review AI stock analysis and investor report context for ALXO:NASDAQ.
Alx Oncology Holdings Inc. company profile
View the public company page for Alx Oncology Holdings Inc. on 6ix.
Alx Oncology Holdings Inc. news
Read company news and market updates connected to Alx Oncology Holdings Inc..
Alx Oncology Holdings Inc. investor events
Find investor webinars, events, and replay context for Alx Oncology Holdings Inc..